Personalized Cell Therapy: A Leading Driver Behind Rising Neurological Disorders Fuel Growth In The Personalized Cell Therapy Market Market Expansion in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Personalized Cell Therapy Industry Market Size Be by 2025?
In recent times, there has been a significant rise in the personalized cell therapy market size. The market, currently valued at $17.11 billion in 2024, will reach $21 billion in 2025, depicting a compound annual growth rate (CAGR) of 22.8%. The robust growth in the historic period is the result of heightened awareness about personalized medicine, amplified healthcare expenditure, increased government efforts, more funding for clinical studies, and a surge in neurological disorders.

What's the Long-Term Growth Forecast for the Personalized Cell Therapy Market Size Through 2029?
In the coming years, a significant surge in growth is projected in the personalized cell therapy market, with the market size expected to rise to $47.14 billion by 2029, reflecting a compound annual growth rate (CAGR) of 22.4%. This expected growth during the forecast period can be ascribed to a surge in clinical trials, escalating rates of chronic diseases, an expanding elderly population, an uptick in cases of cancer, and an increased uptake of regenerative medicine. The major trends anticipated during this forecast period encompass advancements in technology, AI incorporation, personalized vaccines, bioinformatics, and the use of microfluidic technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/personalized-cell-therapy-global-market-report

What Are the Key Growth Drivers Fueling the Personalized Cell Therapy Market Expansion?
The growth of the personalized cell therapy market is projected to be propelled by the increasing prevalence of neurological disorders. These are a set of conditions that impact the brain, nerves, and spinal cord, resulting in symptoms like cognitive declines, sensory disturbances, and impaired motor function. The rising occurrence of neurological disorders can be attributed to an aging population, lifestyle shifts, and environmental stress. Personalized cell therapy can be extremely beneficial for such conditions as it provides custom therapies designed for specific patient needs, possibly repairing damaged neural tissue and enhancing outcomes in complex, individual conditions. For example, the Parkinson Foundation, a government entity based in the U.S. reported in December 2022 that the annual occurrence of Parkinson's disease (PD) amongst the elderly is 50% higher than the present estimate of 60,000 cases. Also, by the year 2030, an additional 1.2 million Americans are expected to suffer from Parkinson's disease. Due to these reasons, the increasing instances of neurological disorders are stimulating the expansion of the personalized cell therapy market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19137&type=smp

What Are the Key Trends Driving Personalized Cell Therapy Market Growth?
Key players in the personalized cell therapy market are prioritizing strategic alliances to hasten the development and commercialization of innovative treatments. Through these collaborations, firms are able to consolidate resources, know-how, and technology to boost their research and development potential, simplify the process of clinical trials, and smoothly navigate the regulatory landscape. In an example from October 2022, biotechnology firm based in the US, Century Therapeutics Inc., collaborated with Bristol Myers Squibb (BMS), a US biopharmaceutical company, to progress the development and commercialization of allogeneic cell treatments. This partnership leverages Century's ground-breaking induced pluripotent stem cell (iPSC) technology to fabricate engineered natural killer (NK) and T cell treatments for hematologic malignancies and solid tumors. The accord involves the progression of as many as four individual cell therapy schemes, with the initial emphasis on acute myeloid leukemia (AML) and multiple myeloma. These plans will employ engineered NK cells or gamma delta T cells derived from iPSCs.

How Is the Personalized Cell Therapy Market Segmented?
The personalized cell therapymarket covered in this report is segmented -

1) By Cell Type: Lymphocytes, Mesenchymal Stem Cell, Hematopoietic Stem Cell, Other Cell Type
2) By Technique: Platelet Transfusions, Bone Marrow Transplantation, Packed Red Cell Transfusions, Organ Transplantation
3) By Application: Cardiovascular Diseases, Neurological Disorders, Inflammatory Diseases, Diabetes, Cancer, Other Applications
4) By End-User: Hospital, Homecare, Specialty Clinics, Other End-User

Subsegments:
1) By Lymphocytes: T Cells, Natural Killer (NK) Cells, Regulatory T Cells
2) By Mesenchymal Stem Cells (MSCs): Bone Marrow-Derived MSCs, Adipose Tissue-Derived MSCs, Umbilical Cord-Derived MSCs
3) By Hematopoietic Stem Cells: Autologous Hematopoietic Stem Cells, Allogeneic Hematopoietic Stem Cells
4) By Other Cell Types: Dendritic Cells, Fibroblasts, Endothelial Cells

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19137&type=smp

Which Companies Are Leading the Charge in Personalized Cell Therapy Market Innovation?
Major companies operating in the personalized cell therapy marker are AbbVie Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Gilead Sciences Inc., Cipla Limited, Poseida Therapeutics Inc., Sangamo Therapeutics Inc., Nkarta Therapeutics Inc., Intellia Therapeutics Inc., Tessa Therapeutics Pte Ltd., Atara Biotherapeutics Inc., Adaptimmune Therapeutics plc, Precision BioSciences Inc., Editas Medicine Inc., Cellectis S.A., Gracell Biotechnologies Inc., Mesoblast Limited, Fate Therapeutics Inc., Athersys Inc., Bellicum Pharmaceuticals Inc., Celyad Oncology SA, Century Therapeutics Inc., Gamida Cell Ltd., CRISPR Therapeutics AG, Allogene Therapeutics Inc.

Which Regions Are Leading the Global Personalized Cell Therapy Market in Revenue?
North America was the largest region in the personalized cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cell therapy marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19137

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.